Tim Seymour Remains Optimistic About The Long Term Performance Profile Of U.S. Cannabis Equities

On this Cannabis Exclusive Podcast, TDR Founder Shadd Dales and contributor Anthony Varrell spoke with Tim Seymour. Mr. Seymour is a longtime equity analyst at CNBC, and he also runs the Amplify Seymour Cannabis ETF (ARCX: CNBS). Seymour joins the podcast to talk about the current U.S. cannabis landscape and a variety of issues pertaining to the industry.

On this subject of what makes Tim excited in the industry, he cited opportunities related to mergers & acquisitions. Specifically, he referenced the growing number of receivership assets which are up for grabs on the market right now.

CNBC equity analyst and Amplify Seymour Cannabis ETF portfolio manager, Tim Seymour

Receivership is a legal process in which a court-appointed individual, known as a receiver, takes control of a company’s assets and operations to protect the interests of creditors, stakeholders, and other parties involved in the business. The receiver’s role is to manage the company’s affairs in a way that maximizes the value of its assets and helps to pay off its debts.

Receiverships are typically initiated when a company is insolvent, meaning that it cannot meet its financial obligations and may be at risk of bankruptcy or liquidation. In such cases, a receiver may be appointed by a court, a secured creditor, or other parties with a legal interest in the company’s assets.

Tim Seymour also provided support for embattled cannabis investors which have been hit with a constant stream of declining equity prices. He reiterated that the cannabis industry would be a “huge destination for capital at some point”, presumably when federal reform progresses. He also noted that in his experience, “you make the most money when things go from terrible to just bad.”

Undoubtedly, that’s a state of things in the present U.S. cannabis market, with the latest Congressional gambit on SAFE Banking reform perhaps bringing us to a better place.

To view our previous TDR Podcast featuring Mindmed CEO Robert Barrow, click here.

You might also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More